Germline vs. somatic BRCA mutations and response to chemotherapy and outcomes in serous ovarian cancer

被引：0
|
作者：
Chan, J. K. [1 ]
Kiet, T. K. [1 ]
Chen, L. [1 ]
Ruskin, R. [1 ]
Sherman, A. E. [1 ]
Monk, B. J. [2 ]
Kapp, D. S. [3 ]
Krivak, T. C. [4 ]
机构：
[1] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Gynecol Oncol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[2] Creighton Univ, Sch Med, St Josephs Hosp & Med Ctr, Dept Obstet & Gynecol,Div Gynecol Oncol, Phoenix, AZ USA
[3] Stanford Canc Ctr, Dept Radiat Oncol, Stanford, CA USA
[4] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA
来源：
GYNECOLOGIC ONCOLOGY | 2011年 / 123卷 / 02期
关键词：
D O I：
10.1016/j.ygyno.2011.07.055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：436 / 436
页数：1
相关论文
共 50 条
  • [21] Temporal Patterns and Adoption of Germline and Somatic BRCA Testing in Ovarian Cancer
    Huepenbecker, Sarah P.
    Wright, Jason D.
    Downer, Mary K.
    Incerti, Devin
    Luhn, Patricia
    Dolado, Ignacio
    Bastiere-Truchot, Lydie
    Lin, Yvonne G.
    Chan, John K.
    Meyer, Larissa A.
    OBSTETRICS AND GYNECOLOGY, 2022, 140 (05): : 758 - 767
  • [22] Characterizing somatic mutations in ovarian cancer germline risk regions
    Ping-Hung Lai
    Jonathan P. Tyrer
    Paul Pharoah
    Simon A. Gayther
    Michelle R. Jones
    Pei-Chen Peng
    Communications Biology, 8 (1)
  • [23] Routine germline BRCA testing in serous ovarian cancer: The West of Scotland experience
    Spiliopoulou, P.
    Gibson, S.
    Davidson, R.
    Glasspool, R.
    McNeish, I.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S554 - S554
  • [24] Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer
    Chao, Angel
    Chang, Ting-Chang
    Lapke, Nina
    Jung, Shih-Ming
    Chi, Peter
    Chen, Chien-Hung
    Yang, Lan-Yan
    Lin, Cheng-Tao
    Huang, Huei-Jean
    Chou, Hung-Hsueh
    Liou, Jui-Der
    Chen, Shu-Jen
    Wang, Tzu-Hao
    Lai, Chyong-Huey
    ONCOTARGET, 2016, 7 (51) : 85529 - 85541
  • [25] Somatic hypermutation and outcomes of platinum based chemotherapy in patients with high grade serous ovarian cancer
    Sohn, Insuk
    Jung, Woon Yong
    Sung, Chang Ohk
    GYNECOLOGIC ONCOLOGY, 2012, 126 (01) : 103 - 108
  • [26] Ovarian Aging in Women With BRCA Germline Mutations
    Lin, Wayne
    Titus, Shiny
    Moy, Fred
    Ginsburg, Elizabeth S.
    Oktay, Kutluk
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (10): : 3839 - 3847
  • [27] The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer
    Meisel, J. L.
    Hyman, D. M.
    Garg, K.
    Zhou, Q.
    Dao, F.
    Bisogna, M.
    Gao, J.
    Schultz, N. D.
    Grisham, R. N.
    Phillips, M.
    Iasonos, A.
    Kauff, N. D.
    Levine, D. A.
    Soslow, R. A.
    Spriggs, D. R.
    ANNALS OF ONCOLOGY, 2014, 25 (12) : 2372 - +
  • [28] Temporal Patterns and Adoption of Germline and Somatic BRCA Testing Ovarian Cancer.
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (02)
  • [29] Germline and somatic homologous recombination gene mutations in high-grade serous ovarian cancer and clinical outcome.
    Mandilaras, Victoria
    Lheureux, Stephanie
    Stjepanovic, Neda
    Burnier, Julia
    Wilson, Michelle K.
    Wang, Lisa
    Clarke, Blaise
    Shaw, Patricia Ann
    Berman, Hal K.
    Kim, Raymond
    Armel, Susan Randall
    McCuaig, Jeanna
    Volenik, Alexandra
    Ahmed, Lailah
    Misyura, Maksym
    Bedard, Philippe L.
    Siu, Lillian L.
    Kamel-Reid, Suzanne
    Stockley, Tracy
    Oza, Amit M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [30] Routine germline BRCA testing in serous ovarian cancer: The West of Scotland experience.
    Spiliopoulou, Pavlina
    Gibson, Sarah
    Davidson, Rosemarie
    Glasspool, Rosalind Margaret
    McNeish, Iain A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345